Epigral Ltd share price logo

Epigral Ltd

NSE: EPIGRAL

BSE: 543332

Small Cap

Chemical Sector

Petrochemical Sector

₹951.50

+77.00

(+8.81%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Epigral shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-13%

Searches for Epigral on INDmoney have decreased by 13% over the last 30 days.

Among the most traded stocks

390th

Epigral was the 390th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

40 days

INDmoney investors hold Epigral shares for an average of 40 days.

Key Events for Epigral

Last Dividend Declared

₹5.00 per share, declared on 02/05/2026

View Dividend History

Epigral Stock Performance

as on November 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹873.60
    ₹957.80
    downward going graph

    8.19%

    Downside

    0.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹807.00
    ₹1,729.90
    downward going graph

    15.19%

    Downside

    81.81%

    Upside

    downward going graph

Epigral share price movements today

Previous Close
₹874.50
Open
₹879.85
Volume
5.08L
Upper Circuit
₹1,049.40
Lower Circuit
₹699.60
Day's Low - High
₹873.60 - ₹957.80
52 Week Low - High
₹807.00 - ₹1,729.90

Epigral Historical Returns

1 Month Return
-14.04 %
3 Month Return
-21.97 %
1 Year Return
-48.49 %
3 Year Return
-2.91 %
5 Year Return
+ 1.2 %

Epigral Fundamentals

as on November 2, 2026 at 4:01 pm IST

Market Cap

₹3,772.71 Cr

Return on Equity (ROE)

16.15

PE Ratio (TTM)

13.92

Return on capital employed (ROCE)

15.57

Industry PE ratio

45.69

Beta (LTM)

1.25

P/B Ratio

1.57

Dividend Yield

0.62

PEG Ratio

-0.36

Quarterly Earnings Growth YOY

27.06

EPS (TTM)

76.95

Book Value

514.94

Epigral Stock Valuation

as on November 2, 2026 at 4:01 pm IST

Epigral in the last 5 years

  • Overview

  • Trends

Lowest (9.04x)

March 28, 2023

Today (13.92x)

October 30, 2026

Industry (45.69x)

October 30, 2026

Highest (38.05x)

September 24, 2024

LowHigh

Today’s Price to Earnings Ratio: 13.92x

Epigral Technical Analysis

Track how Epigral technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish12
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.89
Bearish
CCI (20)
-417.26
Bullish
RSI (14)
52.75
Neutral
Momentum (10)
0.75
Bearish
ADI (14)
25.56
Bullish
Ultimate Oscillator (7,14,28)
82.45
Bullish

Moving Averages

Name

Value

Action

SMA (20)
951.44
Bullish
EMA (20)
951.18
Bullish
VWMA (20)
951.32
Bullish
SMA (50)
949.12
Bullish
EMA (50)
948.04
Bullish
SMA (200)
929.59
Bullish
EMA (200)
931.25
Bullish
KAMA (200)
942.53
Bullish
DEMA (200)
948.39
Bullish

Epigral Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Epigral with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Epigral Ltd image
Epigral Ltd
BUY3,772.710.24%0.613312,527
Jaysynth Dyestuff (India) Ltd image
Jaysynth Dyestuff (India) Ltd
NA136.9418.41%0.514140
Yasons Chemex Care Ltd image
Yasons Chemex Care Ltd
NA14.48-15.54%0.62196
Indo Borax & Chemicals Ltd image
Indo Borax & Chemicals Ltd
NA1,247.6632.58%0.5050215
DIC India Ltd image
DIC India Ltd
NA473.773.88%0.0019881
See all

Market expectation of Epigral Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Epigral Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
471.52
524.63
651.2
626.06
645.24
627.63
606.54
587.36
597.12
736.16
705.36
745.99
Other Income
2.46
2.13
2.4
6.32
3.95
3.67
8.53
1.74
5.56
-0.57
4.66
6.48
Total Income
473.98
526.76
653.6
632.38
649.19
631.3
615.07
589.1
602.68
735.59
710.02
752.47
Expenses
348.98
369.24
474.94
447.63
462.73
454.25
443.15
455.3
494.42
568.56
526.16
609.88
Operating Profit
122.54
155.39
176.26
178.43
182.51
173.38
163.39
132.06
102.7
167.6
179.2
136.11
Operating Profit Margin %
25.99%
29.62%
27.07%
28.5%
28.29%
27.62%
26.94%
22.48%
17.2%
22.77%
25.41%
18.25%
Profit Before Interest, Tax and Depreciation
125
157.52
178.66
184.75
186.46
177.05
171.92
133.8
108.26
167.03
183.86
142.59
Interest
20.19
13.69
14.25
27.32
-0.07
11.77
23.37
21.84
10.95
15.8
7.22
10.78
Depreciation
30.88
30.38
33.45
32.25
32.91
33.95
41.54
42.31
42.75
41.69
42.9
44.23
Profit Before Tax
73.93
113.45
130.96
125.18
153.62
131.33
107.01
69.65
54.56
109.54
133.74
87.58
Tax Paid
24.85
36.18
45.09
43.88
49.99
44.44
-53.68
18.43
15.45
28.59
34
22.5
Profit After Tax
49.08
77.27
85.87
81.3
103.63
86.89
160.69
51.22
39.11
80.95
99.74
65.08
Total Net profit including share of profit / Loss from associate company
49.08
77.27
85.87
81.3
103.63
86.89
160.69
51.22
39.11
80.95
99.74
65.08
EPS
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
18.76
23.12
15.09
Actual EPS
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
18.76
23.12
15.09
Adjusted EPS
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
18.76
23.12
15.09
Diluted EPS
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
18.76
23.12
15.09

Epigral Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
828.6
1,550.94
2,188.4
1,929.19
2,550.13
2,527.18
Other Income
2.19
4.11
7.98
6.6
16.2
14.98
Total Income
830.79
1,555.05
2,196.38
1,935.79
2,566.33
2,542.16
Expenses
567.27
1,041.45
1,499.47
1,447.99
1,839.41
1,961.15
Operating Profit
261.33
509.49
688.93
481.2
710.72
566.03
Operating Profit Margin %
31.54%
32.85%
31.48%
24.94%
27.87%
22.4%
Profit Before Interest, Tax and Depreciation
263.52
513.6
696.91
487.8
726.92
581.01
Interest
29.11
44.27
65.5
73.49
53.27
71.96
Depreciation
73.54
85.91
108.95
123.56
132.56
168.29
Profit Before Tax
160.87
383.42
522.46
290.75
541.09
340.76
Tax Paid
60.02
130.63
169.17
94.88
183.4
8.79
Profit After Tax
100.84
252.79
353.29
195.87
357.69
331.97
Total Net profit including share of profit / Loss from associate company
100.84
252.79
353.29
195.87
357.69
331.97
EPS
24.27
60.84
85.03
47.13
84.68
76.95
Actual EPS
24.27
60.84
85.03
47.13
84.68
76.95
Adjusted EPS
24.27
60.84
85.03
47.13
84.68
76.95
Diluted EPS
17.26
60.84
85.03
47.13
84.68
76.95

Epigral Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
229.22
283.82
626.16
397.64
440.56
435.53
Cash Flow from Investing Activities
-196.73
-454.63
-437.21
-401.1
-261.56
-354.67
Cash Flow from Financing Activities
-31.89
195.21
-199.78
-7.6
-163.54
-94.48
Net Cash Flow
0.58
24.41
-10.85
-11.06
15.46
-13.62

Epigral Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
71.38%
71.49%
71.58%
71.58%
68.94%
68.94%
68.95%
68.83%
68.83%
68.83%
68.83%
68.83%
68.83%
DII
0.05%
0.02%
0.18%
1.17%
3.81%
4.31%
4.66%
4.79%
4.92%
5.13%
4.9%
5.56%
4.9%
FII
1.18%
1.36%
1.47%
2.09%
3.02%
3.01%
3.01%
3.05%
2.71%
2.36%
1.54%
1.03%
0.99%
Government
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
27.36%
27.1%
26.74%
25.13%
24.2%
23.72%
23.35%
23.31%
23.52%
23.66%
24.7%
24.55%
25.26%
Total Outstanding Shares
4,15,50,158
4,15,50,158
4,15,50,158
4,15,50,158
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
Total Shareholders
92,959
88,870
85,761
83,176
83,182
81,697
80,878
79,951
78,605
77,562
77,583
76,305
76,384

Mutual Funds Buying / Exiting Epigral

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Epigral

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan Small Cap Fund Direct Growth

Bandhan Small Cap Fund Direct Growth

₹131.03 Cr

₹9.33 Cr (+7.66%)

0.39%

Mutual Funds Exiting Epigral

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Bandhan Business Cycle Fund Direct Growth

Bandhan Business Cycle Fund Direct Growth

₹7.60 Cr

₹0.23 Cr (-2.88%)

0.81%

Motilal Oswal BSE 1000 Index Fund Direct Growth

Motilal Oswal BSE 1000 Index Fund Direct Growth

₹0.00 Cr

₹0.00 Cr (-2.62%)

0.01%

Epigral Corporate Actions

View detailed summary of the earnings and dividend history of Epigral.

  • Epigral Ltd Earnings Results

    Epigral Ltd’s net profit fell -37.93% since last year same period to ₹99.74Cr in the Q1 2026-2027. On a quarterly growth basis, Epigral Ltd has generated 23.21% jump in its net profits since last 3-months.

    Read More

  • Epigral Ltd Dividends May,2026

    In the quarter ending March 2026, Epigral Ltd has declared dividend of ₹5.00 per share on 02 May 2026 - translating a dividend yield of 0.57%.

    Read More about Dividends

Indices Featuring Epigral Stock

Check stock indices that include Epigral.

S&P BSE Commodities

₹7,885.68

+196.41 (▲2.55%)

Insights on Epigral Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 24.55% to 25.26% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 710.02 Cr → 752.47 Cr (in ₹), with an average increase of 5.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Solar Industries India Ltd has given 253.5% return, outperforming this stock by 256.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Solar Industries India Ltd has given 32.8% return, outperforming this stock by 81.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.83% of holdings in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.52% to 4.87% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 99.74 Cr → 65.08 Cr (in ₹), with an average decrease of 34.8% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.03% to 0.99% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, EPIGRAL stock has moved down by -14.0%

About Epigral Ltd

Meghmani Finechem Limited was incorporated in 2007 and is primarily engaged in the manufacturing and selling of Chlor Alkali and its Derivatives, as well as Agrochemicals and Pigments trading. Following the approval from the National Company Law Tribunal NCLT Ahmedabad Bench in May 2021, Meghmani Finechem Limited was demerged from Meghmani Organics in FY 2020-21, and is driven by the second generation of the Promoter family. The Company's Chlor Alkali business has grown from an installed capacity of 188,000 TPA in 2015 to 315,000 TPA. Investments in a Caustic Soda, Hydrogen Peroxide and a 36MW Captive Power Plant have further broadened the Company's manufacturing capacity, with the Payback from these investments being recovered in 45 years. In FY 2020-21, the Company announced the implementation of a 50,000TPA manufacturing facility for Epichlorohydrin ECH and 30,000TPA Chlorinated Polyvinyl Chloride CPVC. The facility is based on glycerin feedstock obtained from 100% renewable resources and is expected to be commissioned in the first quarter of the next financial year. The CPVC Resin project of 30,000TPA is likely to be commissioned by the second quarter of FY 2022-23.

Revenue: ₹745.99Cr as on September 2026 (Q2 FY27)
Net Profit: ₹65.08Cr as on September 2026 (Q2 FY27)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
OrganisationEpigral Ltd
HeadquartersAhmedabad
IndustryChemicals
CEOMaulik Jayantibhai Patel
E-voting on sharesClick here to vote

FAQs

What is Epigral share price today?

Epigral share price today stands at ₹951.5 as on at the close of the market. Epigral share today touched a day high of ₹957.8 and a low of ₹873.6.

What is the 52 week high and 52 week low range for Epigral share?

Epigral touched a 52 week high of ₹1729.9 and a 52 week low of ₹807. Epigral share price today i.e. is closed at ₹951.5, which is -45.00% down from its 52 week high and 17.91% up from its 52 week low.

What is Epigral's market capitalisation today?

Epigral market capitalisation is ₹3,772.71 Cr as on .

How to buy Epigral shares?

To buy Epigral shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for EPIGRAL or Epigral Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Epigral shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Epigral trading volume today?

Epigral trading volume is 5.08L as on . This means that 5.08L shares of Epigral were bought and sold on the stock market during today's trading session.